British journal of anaesthesia
-
Comment Letter Multicenter Study
Effectiveness of acute postoperative pain management.
-
Randomized Controlled Trial Multicenter Study Clinical Trial
Parecoxib sodium has opioid-sparing effects in patients undergoing total knee arthroplasty under spinal anaesthesia.
This multicentre, double-blind, placebo-controlled study compared the opioid-sparing effectiveness and clinical safety of parecoxib sodium over 48 h, in 195 postoperative patients after routine total knee replacement surgery. ⋯ Parecoxib sodium provides opioid-sparing analgesic effects in postoperative patients.
-
Multicenter Study
Patient satisfaction with anaesthesia care: development of a psychometric questionnaire and benchmarking among six hospitals in Switzerland and Austria.
We describe the development and comparison of a psychometric questionnaire on patient satisfaction with anaesthesia care among six hospitals. ⋯ A psychometric questionnaire on patient satisfaction with anaesthesia care must cover areas such as patient information, involvement in decision-making, and contact with the anaesthetist. The assessment using summed scores for dimensions is more informative than a global summed rating. There were significant differences between hospitals. Moreover, the high problem scores indicate a great potential for improvement at all hospitals.
-
Randomized Controlled Trial Multicenter Study Clinical Trial
Randomized crossover comparison of the proseal with the classic laryngeal mask airway in unparalysed anaesthetized patients.
The ProSeal is a wire-reinforced laryngeal mask airway with an additional drain tube that leads to the distal tip of the laryngeal cuff. The design should improve the seal with the larynx. ⋯ The ProSeal is more difficult to insert than the classic laryngeal mask airway but allows positive pressure ventilation more reliably than the classic laryngeal mask airway.
-
Randomized Controlled Trial Multicenter Study Comparative Study Clinical Trial
Ketorolac, diclofenac, and ketoprofen are equally safe for pain relief after major surgery.
Ketorolac is approved for the relief of postoperative pain but concerns have been raised over a possible risk of serious adverse effects and death. Two regulatory reviews in Europe on the safety of ketorolac found the data were inconclusive and lacked comparison with other non-steroidal anti-inflammatory drugs. The aim of this study was to compare the risk of serious adverse effects with ketorolac vs diclofenac or ketoprofen in adult patients after elective major surgery. ⋯ We conclude that ketorolac is as safe as ketoprofen and diclofenac for the treatment of pain after major surgery.